These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2011193)

  • 1. A mediator required for activation of RNA polymerase II transcription in vitro.
    Flanagan PM; Kelleher RJ; Sayre MH; Tschochner H; Kornberg RD
    Nature; 1991 Apr; 350(6317):436-8. PubMed ID: 2011193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
    Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
    Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNA polymerase II holoenzyme responsive to activators.
    Koleske AJ; Young RA
    Nature; 1994 Mar; 368(6470):466-9. PubMed ID: 8133894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of activation-defective TBP mutations on transcription initiation in yeast.
    Kim TK; Hashimoto S; Kelleher RJ; Flanagan PM; Kornberg RD; Horikoshi M; Roeder RG
    Nature; 1994 May; 369(6477):252-5. PubMed ID: 8183347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transcription reinitiation intermediate that is stabilized by activator.
    Yudkovsky N; Ranish JA; Hahn S
    Nature; 2000 Nov; 408(6809):225-9. PubMed ID: 11089979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of TBP to promoters in vivo is stimulated by activators and requires Pol II holoenzyme.
    Kuras L; Struhl K
    Nature; 1999 Jun; 399(6736):609-13. PubMed ID: 10376605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBP-associated factors are not generally required for transcriptional activation in yeast.
    Moqtaderi Z; Bai Y; Poon D; Weil PA; Struhl K
    Nature; 1996 Sep; 383(6596):188-91. PubMed ID: 8774887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of TBP binding by activators and general transcription factors.
    Li XY; Virbasius A; Zhu X; Green MR
    Nature; 1999 Jun; 399(6736):605-9. PubMed ID: 10376604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of transcriptional activation and repression can both involve TFIID.
    Manley JL; Um M; Li C; Ashali H
    Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):517-26. PubMed ID: 8735274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of DNA replication in yeast by recruitment of the RNA polymerase II transcription complex.
    Stagljar I; Hübscher U; Barberis A
    Biol Chem; 1999 May; 380(5):525-30. PubMed ID: 10384958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DSIF contributes to transcriptional activation by DNA-binding activators by preventing pausing during transcription elongation.
    Zhu W; Wada T; Okabe S; Taneda T; Yamaguchi Y; Handa H
    Nucleic Acids Res; 2007; 35(12):4064-75. PubMed ID: 17567605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mediator coactivator complex: functional and physical roles in transcriptional regulation.
    Lewis BA; Reinberg D
    J Cell Sci; 2003 Sep; 116(Pt 18):3667-75. PubMed ID: 12917354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative effect of the transcriptional activator GAL4.
    Gill G; Ptashne M
    Nature; 1988 Aug; 334(6184):721-4. PubMed ID: 3412449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of Swi/Snf to the yeast GAL1 UAS G requires the Mediator, TAF IIs, and RNA polymerase II.
    Lemieux K; Gaudreau L
    EMBO J; 2004 Oct; 23(20):4040-50. PubMed ID: 15385957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent recruitment of mediator and SAGA by the activator Met4.
    Leroy C; Cormier L; Kuras L
    Mol Cell Biol; 2006 Apr; 26(8):3149-63. PubMed ID: 16581789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mammalian SRB protein associated with an RNA polymerase II holoenzyme.
    Chao DM; Gadbois EL; Murray PJ; Anderson SF; Sonu MS; Parvin JD; Young RA
    Nature; 1996 Mar; 380(6569):82-5. PubMed ID: 8598913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gal11p dosage-compensates transcriptional activator deletions via Taf14p.
    Lim MK; Tang V; Le Saux A; Schüller J; Bongards C; Lehming N
    J Mol Biol; 2007 Nov; 374(1):9-23. PubMed ID: 17919657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID.
    Yuan H; Yoza BK; Lyles DS
    Virology; 1998 Nov; 251(2):383-92. PubMed ID: 9837802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mediator between activator proteins and the RNA polymerase II transcription apparatus.
    Kelleher RJ; Flanagan PM; Kornberg RD
    Cell; 1990 Jun; 61(7):1209-15. PubMed ID: 2163759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.